Michaela Johnson
Education
M.B.A., MIT Sloan School of Management; B.A., neuroscience, Bowdoin College
Summary of Experience
Ms. Johnson has worked extensively on health care analytics projects, focusing on the application of economic and statistical methods in health economics and complex litigation settings. She has supported testifying experts and counsel on issues related to alleged kickbacks, off-label marketing, and delayed generic entry. Ms. Johnson has experience managing complex projects and collecting and analyzing a variety of different types of data. She has presented a number of abstracts and published on health economics topics across a diverse array of therapeutic areas, including multiple sclerosis, vaccinations, and autoimmune diseases.
-
Economic Burden of Non-Infectious Inflammatory Eye Disease (NIIED) in a Commercially-Insured Population in the United States
Ocular Immunology and Inflammation, 2020
2020Albini TA, Rice JB, White AG, Johnson M, Reiff J, Lima AF, Bartels-Peculis L, Ciepielewska G, Nelson WW
-
Predictors of High-cost Patients With Noninfectious Inflammatory Eye Diseases
Clinical Therapeutics, 2019
2019Nelson WW, Rice JB, White AG, Johnson M, Reiff J, Lima AF, Bartels-Peculis L, Ciepielewska G, Albini TA
-
Are Payers Ready to Address the Financial Challenges Associated with Gene Therapy?
Health Affairs, June 28, 2018
2018
